Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-24T06:14:05.229Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of treatment adherence in patients with mental illness

Published online by Cambridge University Press:  01 September 2022

H. Jemli ,
R. Jomli ,
H. Ghabi ,
U. Ouali ,
M. Ben Amor  and
Y. Zgueb
H. Jemli
Affiliation:
university of tunis elmanar, Faculty Of Medicine Of Tunis, manouba, Tunisia
R. Jomli*
Affiliation:
Razi Hospital, Psychiatry A, manouba, Tunisia
H. Ghabi
Affiliation:
university of tunis elmanar, Faculty Of Medicine Of Tunis, manouba, Tunisia
U. Ouali
Affiliation:
Razi Hospital, Psychiatry A, manouba, Tunisia
M. Ben Amor
Affiliation:
university of tunis elmanar, Faculty Of Medicine Of Tunis, manouba, Tunisia
Y. Zgueb
Affiliation:
Razi Hospital, Psychiatry A, manouba, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Treatment adherence, is defined as “the extent to which a person’s behavior — taking medication, following a diet, and/or executing lifestyle changes — corresponds with the agreed recommendations from a healthcare provider.” The course of patients with mental health is habitually chronic and based on an indefinite continuation of treatment to sustain remission and prevent relapses. Treatment adherence issues are the main obstacles in the management of these patients

Objectives

The aim of the present study was to evaluate treatment adherence in patients with mental health and the demogrphic and clinical factors associated with it.

Methods

It was a cross-sectional study conduced at the department of Psychiatry A at Razi Hospital.The validated arabic version of Morisky-Green test was used to assess medication adherence. The patients were considered as adherent if they answered ‘No ’ to all questions

Results

60 patients were included, with a sex ratio M / F of 0.47. Patients were treated for bipolar disorder type1 in 45% of cases, schizophrenia in 28.3% of cases, schizoaffective disorder in 10% of cases and depressive disorder in 6.7% of cases. 50% of included patients had Moderate level of adherence, 35% were considered as non- adherent and only 13.3% had high adherence. The reported reasons for treatment discontinuation were insight (50%), financial problems (26.9%), side effects (15.4%) and unavailability of drugs (7.7%). The Morisky-Green test score were not correlated neither to the nature of the psychiatric disorder nor to multiple medication.

Conclusions

We found a high proportion of nonadherence in patients with mental illness.

Disclosure

No significant relationships.

Keywords

AdherencepatientTreatmentmental disorder
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S624
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.